Belkyra Injectable Kybella Injectable Safe Injectable Fat Dissolving for Reduce and Eliminate Excess Fat Under Chin Double Belly Slim Patch Ozem Pic Weight Loss

• Customization: Available
• MOQ: 1box
• Transport Package: Box
• Model NO.: Belkyra
• Specification: 2ml*4 vails
• Origin: South Korea
• Production Capacity: 100000PCS/Week

Product Description

BELKYRA KEY FEATURES AND BENEFITS

BELKYRA™ (deoxycholic acid) is an injectable treatment designed to reduce submental fat (double chin). It works by breaking down fat cells, which are then naturally eliminated by the body. Belkyra is an FDA approved injectable treatment that destroys fat cells. It is also known as Kybella.

Medical professionals may offer Belkyra, an injectable prescription medicine that contains deoxycholic acid as the active ingredient, to deliver the following benefits to individuals who wish to restore their confidence and youthful facial look.

• Clinically Proven Fat Reduction: Targets stubborn submental fat with long-lasting results.
• Non-Surgical and Minimally Invasive: No incisions or anesthesia required.
• Customized Treatment: Patients receive multiple small injections in 2-6 sessions, depending on their needs.
• Permanent Fat Cell Destruction: Once destroyed, fat cells do not regenerate.
• Fast Procedure and Recovery: Treatments take 15-20 minutes, with minimal downtime.

BELKYRA TREATMENT INDICATIONS

AbbVie designed this non-surgical injection mainly to aid the aesthetic needs of individuals with concerns about their double chin. BELKYRA™ is specifically indicated for the treatment of moderate to severe submental fat (fat under the chin) in adults.

• For individuals with excess submental fat that causes aesthetic concerns.
• Not suitable for obese patients or those with significant skin laxity.
• Should not be used in individuals with infections or previous complications in the treatment area.

COMPLETE LIST OF INGREDIENTS

Patients should find this treatment appealing and convenient, as Belkyra non-surgically reduces fat under the chin. Using the combination of potent and natural components to provide a safe and effective treatment, each vial of BELKYRA™ contains:

• Active Ingredient: Deoxycholic acid (10 mg/mL) - a naturally occurring molecule that helps break down dietary fat.
• Other Ingredients:
  • Water for Injection
  • Sodium chloride
  • Sodium hydroxide (pH adjustment)
  • Hydrochloric acid (pH adjustment)
  • Disodium phosphate anhydrous

HOW TO USE BELKYRA™ TO TREAT DOUBLE CHIN

A qualified healthcare professional must administer BELKYRA™ through multiple small subcutaneous injections into the fat layer beneath the chin. The recommended treatment protocol of a Belkyra injection is as follows:

• Preparation:
  • Using ice or cold packs, topical or injectable local anesthesia can improve patient comfort.
  • Outline the treatment area with a surgical pen and apply a 1 cm injection grid to mark the injection sites.
• Injection Pattern:
  • Each treatment consists of up to 50 small injections advancing the needle perpendicular to the skin.
  • Injected in a 1 cm grid pattern across the submental area.
• Dosage and Treatment Sessions:
  • 0.2 mL per injection site
  • Maximum 10 mL per session.
  • A minimum of 4 weeks between sessions.
  • Most patients require 2-4 sessions (up to 6 maximum).

When the non-surgical injectable treatment reaches the injection site and localized subcutaneous fat, the deoxycholic acid disrupts the cell membranes of adipocytes, leading to cell lysis. This destruction triggers a tissue response, where macrophages are drawn to the area to clear cellular debris and lipids through natural processes. Subsequently, fibroblasts appear, and there is an observed thickening of fibrous septa, likely due to increased collagen production (neocollagenesis).

BELKYRA TREATMENT SIDE EFFECTS

Despite its favorable safety profile and being the only FDA approved treatment for double chin fat, medical professionals must equip patients with comprehensive information about Belkyra's side effects. While BELKYRA™ is generally well-tolerated, some patients may experience mild to moderate side effects.

• Very Common Side Effects (≥1 in 10 patients):
  • Pain, swelling, and redness at injection sites.
  • Numbness, and hardness in the treated area.
• Common Side Effects (≥1 in 100 patients):
  • Bleeding, warmth, or color changes in the skin.
  • Jaw nerve injury, causing temporary facial asymmetry.
  • Mild difficulty in swallowing (dysphagia).
• Rare Side Effects (≥1 in 1,000 patients):
  • Skin ulceration and necrosis (tissue damage requiring medical attention).
  • Allergic reactions, manifested as hives (urticaria), rash, or trouble breathing.
  • Temporary difficulty in speaking (dysphonia).

BELKYRA™ CLINICAL STUDIES

BELKYRA™ has undergone multiple clinical trials demonstrating its effectiveness and safety for reducing submental fat.

• Clinical Efficacy Trials:
  • 68.2% of subjects treated achieved a composite response of ≥ 1-grade.
  • 16.0% of subjects experienced a ≥ 2-grade composite improvement.
  • 79% of patients reported increased satisfaction with the appearance of the area beneath the chin.
  • Patients also reported more significant improvements in the visual and emotional impact of submental fat
• Safety Data:
  • Side effects were mild to moderate and resolved within 4 weeks.
  • No long-term complications reported in controlled trials.

BRAND'S MANUFACTURER INFORMATION

• Manufacturer: AbbVie Ltd.
• Production Facilities:
  • Almac Pharma Services, UK
  • Allergan Pharmaceuticals, Ireland
• Regulatory Approval: Approved by the FDA, EMA, and other global health authorities.

BELKYRA TREATMENT FAQ

1. How long does BELKYRA™ take to show results?

• Most patients see visible results within 2-4 sessions over 2-3 months.

1. Is BELKYRA™ a permanent solution?

• Yes, fat cells destroyed by BELKYRA™ do not regenerate, providing long-lasting results.

1. How painful is BELKYRA™ treatment?

• Patients may experience mild discomfort or stinging, which can be managed with local anesthesia or ice packs.

1. Can BELKYRA™ be used for fat reduction in areas other than the chin?

• No, BELKYRA™ is only approved for submental fat treatment.

1. What should I avoid after receiving BELKYRA™ injections?

• Avoid alcohol, strenuous exercise, and excessive sun exposure for 48 hours post-treatment.

1. Can BELKYRA™ be combined with other aesthetic treatments?

• Yes, it can be used alongside fillers, Botox, or skin-tightening procedures, as recommended by a doctor.

Belkyra Injectable Kybella Injectable Safe Injectable Fat Dissolving for Reduce and Eliminate Excess Fat Under Chin Double Belly Slim Patch Ozem Pic Weight Loss